NEW YORK — Kenvue, the manufacturer of Tylenol, the best-selling form of acetaminophen, said Monday that it “strongly disagrees” with President Donald Trump’s suggestion that its drug may cause autism.
In a White House announcement, Trump on Monday promoted unproven ties between Tylenol, vaccines and autism without offering any new evidence.
In a statement, Kenvue told the WSJ the company has "continuously evaluated the science and [continues] to believe there is no causal link" between acetaminophen, pregnancy and autism. Kenvue added that the FDA and leading medical organizations "agree on the safety" of the drug, its use for pregnancy and information provided on the Tylenol label. The FDA website says the agency has not found "clear evidence" that appropriate use of acetaminophen during pregnancy causes adverse pregnancy, birth, neurobehavioral, or developmental outcomes."
